RG6505
/ Roche
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
April 18, 2025
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Clinical Activity of RO7673396 in Participants With Advanced Solid Tumors Harboring Rat Sarcoma Viral Oncogene Homolog (RAS) Mutation(s)
(clinicaltrials.gov)
- P1 | N=345 | Recruiting | Sponsor: Hoffmann-La Roche | Not yet recruiting ➔ Recruiting
Enrollment open • Oncology • Sarcoma • Solid Tumor
March 19, 2025
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Clinical Activity of RO7673396 in Participants With Advanced Solid Tumors Harboring Rat Sarcoma Viral Oncogene Homolog (RAS) Mutation(s)
(clinicaltrials.gov)
- P1 | N=345 | Not yet recruiting | Sponsor: Hoffmann-La Roche
New P1 trial • Oncology • Sarcoma • Solid Tumor
1 to 2
Of
2
Go to page
1